Aurobindo Pharma’s subsidiary Eugia secures FDA nod for pazopanib tablets

Pallavi Madhiraju- December 6, 2024 0

Aurobindo Pharma Limited, through its wholly owned subsidiary Eugia Pharma Specialities Limited, has received final approval from the US Food and Drug Administration (USFDA) to ... Read More

Aurobindo Pharma USA announces strategic partnership for respiratory drugs

Pallavi Madhiraju- November 25, 2024 0

Aurobindo Pharma USA Inc., a wholly owned subsidiary of Aurobindo Pharma Limited, has secured a major collaboration and license agreement with an unnamed global pharmaceutical ... Read More

PM Modi inaugurates Lyfius Pharma’s Rs 2,500cr Penicillin-G facility in Kakinada

Pallavi Madhiraju- October 30, 2024 0

Prime Minister Narendra Modi inaugurated Lyfius Pharma’s flagship Penicillin-G manufacturing facility in Kakinada, Andhra Pradesh, marking a major milestone for India’s pharmaceutical industry. The facility, ... Read More

Aurobindo Pharma gains FDA approval for Mometasone Furoate Monohydrate Nasal Spray

Pallavi Madhiraju- March 19, 2024 0

In a major development within the pharmaceutical industry, Aurobindo Pharma Limited (Aurobindo) announced it has received final approval from the US Food & Drug Administration ... Read More

CuraTeQ Biologics achieves milestone in Omalizumab biosimilar development

Pallavi Madhiraju- March 15, 2024 0

CuraTeQ Biologics Private Limited, a fully integrated arm of Aurobindo Pharma Ltd, has announced significant progress in its biosimilar program, revealing that its Omalizumab biosimilar ... Read More

Aurobindo Pharma reports strong growth in Q3FY24 with record sales and EBITDA

Pallavi Madhiraju- February 10, 2024 0

Aurobindo Pharma Limited, a leading player in the pharmaceutical sector, has announced its consolidated financial results for the quarter ended December 31, 2023. The company ... Read More

Aurobindo Pharma gains FDA approval for Darunavir Tablets

Pallavi Madhiraju- November 29, 2023 0

Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Darunavir Tablets, 600 mg and 800 ... Read More

FDA approves Ryzneuta by Evive Biotech for reducing febrile neutropenia in cancer patients

Pallavi Madhiraju- November 22, 2023 0

Evive Biotech, a global biopharmaceutical company and a subsidiary of Yifan Pharmaceutical Co. Ltd., along with New Jersey-based Acrotech Biopharma, a wholly-owned subsidiary of Aurobindo ... Read More

Aurobindo Pharma subsidiary earns FDA approval for Testosterone Cypionate Injection

Pallavi Madhiraju- October 25, 2023 0

In a significant development for the pharmaceutical industry, Aurobindo Pharma Limited's dedicated subsidiary, Eugia Pharma Specialities Limited, has triumphantly gained the final nod from the ... Read More

Aurobindo Pharma’s subsidiary Eugia Pharma gets FDA approval for Icatibant Injection

Pallavi Madhiraju- August 16, 2023 0

In a pivotal move bolstering its footprint in the global pharmaceutical landscape, Aurobindo Pharma Limited's subsidiary, Eugia Pharma Specialities Limited, has achieved final authorization from ... Read More